Potential Masking Effects of Salmeterol on Airway Inflammation in Asthma
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
We hypothesized that regular use of long-acting beta-agonists could delay recognition of ("mask") increasing airway inflammation. We studied steroid-sparing and "masking" effects of salmeterol versus placebo in 13 asthmatic individuals requiring >= 1,500 microgram inhaled corticosteroid daily. Corticosteroid doses were reduced weekly until criteria were met for an exacerbation or the corticosteroid was fully withdrawn. Subjects were restabilized on their original dose of inhaled corticosteroid for 4 wk before crossover to the alternative treatment. Subjects maintained symptom and peak expiratory flow (PEF) diaries, and underwent weekly spirometric, methacholine challenge, sputum eosinophil, and serum eosinophil cationic protein (ECP) measurements. Mean corticosteroid dose was reduced by 87% during salmeterol treatment, versus 69% with placebo (p = 0.04). Sputum eosinophils increased before exacerbation despite stable symptoms, FEV1, and PEF. In the week before clinical exacerbation, sputum eosinophil counts were higher in the salmeterol-treatment arm (19.9 +/- 29.8% [mean +/- SD], versus placebo 9.3 +/- 17.6%; p = 0.006). Five subjects showed > 10% sputum eosinophilia before exacerbation during salmeterol treatment, as compared with two receiving placebo. In this model, salmeterol controlled symptoms and lung function until inflammation became significantly more advanced. We conclude that the bronchodilating and symptom-relieving effects of salmeterol can mask increasing inflammation and delay awareness of worsening asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
Standardization of Spirometry — 1987 Update
Buist, A. S. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1073 · Cited by 3,266
Bronchial reactivity to inhaled histamine: a method and clinical survey
COCKCROFT, D. W., KILLIAN, D. N., MELLON, J. J. A., & HARGREAVE, F. E. (1977) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1977.tb01448.x · Cited by 1,840
Self-citationEffect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
Pauwels, R. A., Löfdahl, C.-G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., & Ullman, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372001 · Cited by 1,520
Greening, A. P., Ind, P. W., Northfield, M., & Shaw, G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92996-3 · Cited by 972
Pizzichini, E., Pizzichini, M. M., Efthimiadis, A., Evans, S., Morris, M. M., Squillace, D., Gleich, G. J., Dolovich, J., & Hargreave, F. E. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.2.8756799 · Cited by 966
Self-citationEffect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
(1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380222 · Cited by 864
Woolcock, A., Lundback, B., Ringdal, N., & Jacques, L. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630590 · Cited by 701
Use of Inhaled Corticosteroids and the Risk of Cataracts
Cumming, R. G., Mitchell, P., & Leeder, S. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370102 · Cited by 520
A scale for the measurement of quality of life in adults with asthma
Marks, G. B., Dunn, S. M., & Woolcock, A. J. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90095-5 · Cited by 394
A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma
Pearlman, D. S., Chervinsky, P., LaForce, C., Seltzer, J. M., Southern, D. L., Kemp, J. P., Dockhorn, R. J., Grossman, J., Liddle, R. F., Yancey, S. W., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272004 · Cited by 362
Pizzichini, E., Pizzichini, M., Efthimiadis, A., Hargreave, F., & Dolovich, J. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09061174 · Cited by 298
Self-citationGIBSON, P. G., WONG, B. J. O., HEPPERLE, M. J. E., KLINE, P. A., GIRGIS‐GABARDO, A., GUYATT, G., DOLOVICH, J., DENBURG, J. A., RAMSDALE, E. H., & HARGREAVE, F. E. (1992) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1992.tb00161.x · Cited by 198
Self-citationIssues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.
Kamada, A. K., Szefler, S. J., Martin, R. J., Boushey, H. A., Chinchilli, V. M., Drazen, J. M., Fish, J. E., Israel, E., Lazarus, S. C., & Lemanske, R. F. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665030 · Cited by 192
Toogood, J. H., Baskerville, J. C., Markov, A. E., Hodsman, A. B., Fraher, L. J., Jennings, B., Haddad, R. G., & Drost, D. J. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70003-x · Cited by 116
Formoterol Compared with Beclomethasone and Placebo on Allergen-induced Asthmatic Responses
Wong, B., Dolovich, J., Ramsdale, E. H., O’Byrne, P. M., Gontovnick, L., Denburg, J. A., & Hargreave, F. E. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.5_pt_1.1156 · Cited by 100
Self-citationInhaled formoterol during one year in asthma: a comparison with salbutamol
Arvidsson, P., Larsson, S., Lofdahl, C., Melander, B., Svedmyr, N., & Wåhlander, L. (1991) · European Respiratory Journal · doi:10.1183/09031936.93.04101168 · Cited by 96
Pizzichini, M. M. M., Kidney, J., Wong, B., Morris, M. J., Efthimiadis, A., Dolovich, J., & Hargreave, F. E. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09030449 · Cited by 81
Self-citationPeak expiratory flow and the resistance of the mini-wright peak flow meter
Pedersen, O., Rasmussen, T. R., Omland, Ø., Sigsgaard, T., Quanjer, P. H., & Miller, M. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09040828 · Cited by 46
Pepys, J. (1994) · Allergy · doi:10.1111/j.1398-9995.1994.tb00830.x · Cited by 45
Self-Control and External Control of Mechanical Ventilation Give Equal Air Hunger Relief
Bloch‐Salisbury, E., Spengler, C. M., BROWN, R., & Banzett, R. B. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9701024 · Cited by 33
Cited by
Treatment strategies for allergy and asthma
Holgate, S. T., & Polosa, R. (2008) · Nature Reviews Immunology · doi:10.1038/nri2262 · Cited by 691
Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma
O'Byrne, P. M., Bisgaard, H., Godard, P. P., Pistolesi, M., Palmqvist, M., Zhu, Y., Ekström, T., & Bateman, E. D. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-884oc · Cited by 657
“Also, concerns that the use of the LABA alone may mask subclinical airway inflammation (19) are not an issue with bud/form for maintenance and relief, as ICSs are always delivered with reliever medication to control underlying inflammation.”
Salpeter, S. R., Buckley, N. S., Ormiston, T. M., & Salpeter, E. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00126 · Cited by 461
Exacerbations of Asthma: A Descriptive Study of 425 Severe Exacerbations
TATTERSFIELD, A. E., POSTMA, D. S., BARNES, P. J., SVENSSON, K., BAUER, C.-A., O'BYRNE, P. M., LÖFDAHL, C.-G., PAUWELS, R. A., & ULLMAN, A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9811100 · Cited by 386
Metadata
- Authors
- ANDREW McIVOR, R., PIZZICHINI, E., TURNER, M. O., HUSSACK, P., HARGREAVE, F. E., & SEARS, M. R.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-09-01
- Volume
- 158
- Issue
- 3
- Pages
- 924-930
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2107458343
- Cited by
- 283
- References
- 21
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.